Ilyang to spur vaccine development

In an effort to develop a variety of vaccines for influenza, food and mouth disease, dengue fever and rabies, Ilyang Pharmaceutical Co, signed a memorandum of understanding with Taiwan based Medigen Biotechnology Corporation on January 18 to make joint research and development based on the latter’s independent cell-culture technology.

The deal gives Ilyang exclusive rights to produce seasona...